Seaport Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $225,000,000
Company Info
- Company Description
- Seaport Therapeutics is a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team.
- Market
- Neuropsychiatric medicines
- Location
- Boston, MA, USA
- Coinvestors
- General Atlantic, T. Rowe Price Associates, Inc., Foresite Capital, Invus, Goldman Sachs Alternatives, CPP Investments, ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health